Two patients with colitis and refractory anaemia requiring multiple transfusions are described. In one the anaemia was detected at the onset of colitis before drug treatment; in the other it started after 21 years of treatment with sulphasalazine and during an exacerbation ofcolitis with perianal abscess for which he had just been started receiving prednisolone, cofluampicil and metronidazole. Glomerulonephritis developed two weeks after the onset of anaemia. These findings together with a recent report of four patients with Crohn's disease and refractory anaemia suggests that the association may be more than coincidental and may be immune mediated.
Anaemia is a common finding in inflammatory bowel disease. In severe disease this is usually a normochromic anaemia of chronic disease. In some it may be hypochromic from iron deficiency as a result of blood loss, poor diet or malabsorption. In Crohn's disease it may be macrocytic from folate or B 12 deficiency as a result of small bowel disease or resection. Sulphasalazine may also occasionally predispose to anaemia by folate deficiency or haemolysis. Azathioprine and mercaptopurine, which are reserved for more severe disease, may cause anaemia by marrow depression. We report on two patients with severe anaemia requiring frequent transfusion whose anaemia was refractory and whose bone marrow examination showed myelodysplasia. PATIENT 2 This white man, a former smoker, whose brother had had a colectomy for colitis, was admitted in September 1991 at the age of66 with an exacerbation of colitis first diagnosed in 1969 and a perianal abscess. He had had periodic treatment with sulphasalazine and local steroids. His haemoglobin was 14-0 g/dl with a leucocyte count of 131x109/l, and a platelet count of 106x 109/1. Sigmoidoscopy showed diffuse inflammation with petechial haemorrhages up to 45 cm and from 45-60 cm the mucosa was polypoid. A rectal biopsy specimen showed inflamed mucosa with acute cryptitis. Colonic biopsy specimens showed more severe inflammation with crypt abscesses. No granulomata were seen. He responded to a one month course of prednisolone, sulphasalazine, and drainage of pus from the abscess.
From 29 September to 9 October 1991 he was given oral metronidazole and from 28 September to 1 October he was given cofluampicil. On 1 October he developed a severe erythematous rash and oedema ofhis legs attributed to cofluampicil. Also on 1 October his haemoglobin had fallen to I-1 g/dl and to 5 6 g/l by 4 November. His previously normal urea and creatinine rose to 20 mmol/l and 386 umol/l respectively. They remained at that concentration for a month before improving to a creatinine of 230 ,umol/l and a normal urea. They have remained at that concentration since. A renal biopsy showed a fairly acute immune complex mediated glomerulonephritis, chronic ischaemial hypertensive type damage, and tubular damage possibly related to recent sepsis. Serum C3 complement was reduced at 0 33 g/l; C4 complement was normal. The Table shows 
